Skip to main content

Table 2 Pharmacotherapy profile in patients with NSTE-ACS according to age category

From: Non-ST elevation acute coronary syndromes; clinical landscape, management strategy and in-hospital outcomes: an age perspective

Medication <65 Years ≥ 65 Years p value
N (%)
Aspirina 133 (98.5%) 68 (98.5%) 0.9
P2Y12 inhibitor 134 (99.3%) 65 (100%) 0.4
Heparin 97 (71.9%) 46 (70.8%) 0.8
B-blockers 105 (77.8%) 49 (75.4%) 0.7
Nitrate 80 (59.3%) 42 (64.6%) 0.4
Calcium channel blockers 11 (8.1%) 10 (15.4%) 0.1
ACEI/ARBs 57 (42.2%) 27 (41.5%) 0.9
Statin 123 (91.1%) 53 (81.5%) 0.051
Mineralocorticoid receptor antagonist 9 (6.7%) 12 (18.5%) 0.01
Loop diuretics 21 (15.6%) 16 (24.6%) 0.1
  1. aIncluding a patient with dipyridamole use instead of aspirin because of history of aspirin allergy